Navigation Links
XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
Date:8/6/2008

XTELL has launched a commercial biorepository service, bioVAULT, which stores, manages and processes large numbers of biological specimens. BioVAULT is targeting scientific and pharmaceutical companies investigating new drug and diagnostic development.

Athens, OH (PRWEB) August 5, 2008 -- XTELL announced today the launch of its commercialized, independent biorepository service stemming from its collaborations with The Ohio University Endocrine Diseases Biorepository. XTELL's "bioVAULT" service will provide storage of biological samples derived from human/animal serum and tissues with 100% guaranteed confidentiality. BioVAULT will allow clinicians and researchers alike to facilitate and link patient/family medical history.

XTELL is a biotechnology company founded in 2001, dedicated to both the development of biological specimen storage and electronic medical record software.

A large part of XTELL's success has been from a direct partnership with Ohio University's Diabetes Center in creating a biorepository designed specifically for fundamental and translational research. Samples include DNA, RNA, and protein extracted from blood serum in patients living in a region of the United States with a high prevalence of diabetes and endocrine-related disease. XTELL has developed one of the most advanced diabetes biorepositories of its kind, with a state-of-the-art collection and storage facility.

BioVAULT is now capable of storing, managing and processing large numbers of biological specimens. BioVAULT is targeting scientific and pharmaceutical companies investigating new drug and diagnostic development, as well as universities. "Biorepositories are now critical in understanding the molecular mechanisms of disease and for the development of new therapeutics, " said Anthony Schwartz, President of XTELL.


XTELL is privately held and located in Athens, Ohio and is seeking new investors for building up its infrastructure as well as to secure its long-term growth.

Additional information is available at: http://www.xtell.com

Contact:
XTELL
Anthony Schwartz
President
Telephone: 1.800.314.0735
E-mail: info @ xtellnetworks.com

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1174534.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community
2. Ingenuity Systems Launches Analysis Services
3. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
4. iNutrition Launches New Fission Fruit Nutrition Bars
5. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
6. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
7. Ranbaxy Launches Omeprazole 40 mg Capsules
8. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
9. GeneNews launches worlds first blood test for colorectal cancer screening
10. Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi
11. Health Market Science Launches Clinical Investigators(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies 
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... that it has appointed Vishwas Paralkar to the role of chief scientific officer. ... technology. He will report to Cybrexa’s president and CEO, Per Hellsund. , “I ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... From industry ... therapy succeeded after standard medicine failed. Many of these people had lost all hope. ... Regression Free Download (pdf) , “Neil takes readers on ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... largest group of funded early-stage tech companies. “Grit” author Angela Duckworth and her ... joining the ic@3401 community is Cooley, an international law firm with decades of ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):